Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
0.555
+0.042 (8.22%)
At close: Apr 28, 2026, 4:00 PM EDT
0.559
+0.004 (0.67%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Profusa Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
2.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.27M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.55M |
| Catheter Precision | 819.00K |
| Tivic Health Systems | 482.00K |
PFSA News
- 22 days ago - Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - GlobeNewsWire
- 2 months ago - Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering - GlobeNewsWire
- 2 months ago - Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance - GlobeNewsWire
- 2 months ago - Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies - GlobeNewsWire
- 2 months ago - Profusa Announces 1-for-75 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 - GlobeNewsWire
- 3 months ago - Profusa Stock Spikes As Lumee System Targets Research Market - Benzinga
- 3 months ago - Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue - GlobeNewsWire